Skip to main content
    C

    Cartesian Therapeutics Inc. (RNAC)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $6.12
    +0.04 (+0.66%)

    Market Cap: $193.69M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Cartesian Therapeutics Inc. (RNAC) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Cartesian Therapeutics (RNAC) has a latest price of $6.12 on Nov 17, 2026, 44.4% below its 52-week high of $11.00. Its price fell 18.0% over the past 12 months. The month-end price fell 98.8% over the 10 years through Oct 2026, a compound annual decline of 35.6%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $637.24 in Oct 2017 and its lowest $6.15 in Mar 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart RNAC with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for RNAC.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 41.7%, and over 6 months it rose 0.5%. The month-end price fell 82.7% over the 3 years through Oct 2026, a compound annual decline of 44.3%.

    PeriodChange
    1 month+0.7%
    3 months-41.7%
    6 months+0.5%
    12 months-18.0%
    12 months, with dividends-18.0%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-82.7%-44.3%
    5 years-94.0%-43.0%
    10 years-98.8%-35.6%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price rose 27.3%, and its weakest was 2018, when it fell 72.9%.

    YearCloseChange
    2026 through Oct 2026$6.49-10.0%
    2025$7.21-59.7%
    2024$17.91-13.5%
    2023$20.70-39.0%
    2022$33.93-65.3%
    2021$97.90+7.6%
    2020$90.99+27.3%
    2019$71.47-10.5%
    2018$79.88-72.9%
    2017$294.59-42.8%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 12.9% below its 50-day average of $7.02 and 19.5% below its 200-day average of $7.61.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$6.12
    52-week high$11.00-44.4%
    52-week low$5.60+9.3%
    50-day average$7.02-12.9%
    200-day average$7.61-19.5%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 85.6%.

    MeasureValue
    1-year beta1.35
    Largest fall, 1 year-42.6%
    Largest fall, 3 years-85.6%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About RNAC

    What is RNAC's 1-year price change?

    Cartesian Therapeutics's price fell 18.0% over the past 12 months. With dividends included, the 12-month total return was -18.0%.

    What is RNAC's 5-year price change?

    Cartesian Therapeutics's month-end price fell 94.0% over the 5 years through Oct 2026, a compound annual decline of 43.0%. These figures leave out dividends.

    What is RNAC's 52-week high and low?

    Cartesian Therapeutics's 52-week high is $11.00 and its 52-week low is $5.60. Its latest price of $6.12 on Nov 17, 2026 is 44.4% below the high.

    What is RNAC's beta?

    Cartesian Therapeutics's 1-year beta against the S&P 500 is 1.35, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 42.6%.

    Is the RNAC chart free?

    Yes. Advanced Charting for RNAC is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.